Nutex Health Inc./$NUTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Ticker
$NUTX
Sector
Primary listing
Employees
830
Headquarters
Website
NUTX Metrics
BasicAdvanced
$456M
6.83
$12.01
1.98
-
Price and volume
Market cap
$456M
Beta
1.98
52-week high
$184.28
52-week low
$40.67
Average daily volume
225K
Financial strength
Current ratio
2.274
Quick ratio
2.175
Long term debt to equity
112.947
Total debt to equity
124.185
Dividend payout ratio (TTM)
10.25%
Interest coverage (TTM)
9.65%
Profitability
EBITDA (TTM)
227.275
Gross margin (TTM)
51.95%
Net profit margin (TTM)
10.76%
Operating margin (TTM)
33.39%
Effective tax rate (TTM)
18.90%
Revenue per employee (TTM)
$750,000
Management effectiveness
Return on assets (TTM)
22.34%
Return on equity (TTM)
78.92%
Valuation
Price to earnings (TTM)
6.834
Price to revenue (TTM)
0.691
Price to book
2.3
Price to tangible book (TTM)
2.7
Price to free cash flow (TTM)
6.213
Free cash flow yield (TTM)
16.09%
Free cash flow per share (TTM)
13.206
Growth
Revenue change (TTM)
141.25%
Earnings per share change (TTM)
-232.81%
3-year revenue growth (CAGR)
22.99%
3-year earnings per share growth (CAGR)
-26.91%
Bulls say / Bears say
In Q1 2025, Nutex Health’s revenue soared 213.8% year-over-year to $211.8 million, producing net income of $14.6 million and diluted EPS of $2.56 — the company’s first profitable quarter, driven by successful arbitration outcomes (Investing.com).
Effective June 30, 2025, Nutex Health’s addition to the Russell 3000® and Microcap® indices enhances visibility among passive and institutional investors, potentially driving increased demand for its shares (PR Newswire).
Nutex is investing $36 million to open San Antonio’s first micro-hospital by late 2025, marking its entry into Texas’s second-largest market and demonstrating the scalability of its micro-hospital model (MySA).
Delay in filing Q2 2025 Form 10-Q due to non-cash accounting adjustments for stock-based compensation obligations raised a Nasdaq delinquency notice on August 20, 2025, risking delisting if compliance is not achieved by February 10, 2026 (Nasdaq).
A July 22, 2025 short-seller report by Blue Orca Capital alleged Nutex’s collection processes and revenue recognition were misleading, suggesting much of its arbitration-derived revenue may be uncollectible and undermining investor confidence, prompting an official rebuttal (Reuters).
Robust DOJ enforcement under the False Claims Act in healthcare signals regulatory scrutiny risk for Nutex’s aggressive arbitration model, potentially exposing the company to fraud and abuse investigations (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
NUTX News
AllArticlesVideos
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Business Wire1 week ago
Deadline Approaching: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Business Wire1 week ago
Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action
Business Wire1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nutex Health Inc. stock?
Nutex Health Inc. (NUTX) has a market cap of $456M as of September 05, 2025.
What is the P/E ratio for Nutex Health Inc. stock?
The price to earnings (P/E) ratio for Nutex Health Inc. (NUTX) stock is 6.83 as of September 05, 2025.
Does Nutex Health Inc. stock pay dividends?
No, Nutex Health Inc. (NUTX) stock does not pay dividends to its shareholders as of September 05, 2025.
When is the next Nutex Health Inc. dividend payment date?
Nutex Health Inc. (NUTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Nutex Health Inc.?
Nutex Health Inc. (NUTX) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.